• Fabry Disease Treatment Market Size, Share, Outlook, and Opportunity Analysis - Fabry disease also called as Anderson-Fabry disease and alpha-galactosidase-A deficiency is an X-linked, hereditary, lysosomal storage disease caused due to paucity of an enzyme α galactosidase A (an enzyme required to metabolize lipids, fat-like substances that include oils, waxes, and fatty acids). The mutated gene leads the formation of lipids to harmful levels in various part of body such as the autonomic nervous system, cardiovascular system, eyes, and kidneys. Some of the common symptoms of this multisystem disorder include chronic pain, acroparesthesia, gastrointestinal disturbances, characteristic skin lesions (angiokeratomata), progressive renal impairment, cardiomyopathy, and stroke. Fabry Disease Treatment Market Drivers In recent past, various regulatory bodies of key regions have approved novel medications for treatment of Fabry disease. Approval and launch of such novel medications in the region is expected to significantly support global Fabry disease treatment market growth over the forecast period. For instance, in August 2018, Amicus Therapeutics, Inc., received the U.S. Food and Drug Administration (FDA) approval for its drug Galafold (migalastat). It is the first oral medication indicated for the treatment of adults with Fabry disease. The presence of robust medication pipeline indicated for treatment of Fabry disease is also expected to be a major factor fueling growth of global Fabry disease treatment market over the forecast period. Table mentioned below represents list of some novel therapies in pipeline for Fabry disease treatment. Furthermore, key players in the market are majorly investing in development of novel therapies for Fabry disease treatment, such strategic funding’s by various players is expected to drastically fuel global Fabry Disease treatment market growth over the forecast period. For instance, in February 2018, AvroBio Inc., closed US$ 60 million financing to support the phase 2 study of its novel gene therapy, AVR-RD-01 underdevelopment for the treatment of Fabry disease. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2326 Fabry Disease Treatment Market Regional Analysis Europe Fabry disease treatment market is expected to witness a drastic growth over the forecast period, owing to penetration of key players in key regions of Europe with their novel products for Fabry disease. For instance, Amicus Therapeutics Inc. launched Galafold (Migalastat) for treatment of Fabry disease in Italy (in March 2017) and in Spain (in January 2018) In November 2018, JCR Pharmaceuticals Co., Ltd, a Japan-based company launched biosimilar for agalsidase beta for treatment of Fabry disease. Launch of biosimilars is expected to increase affordability of these therapies in key regions of Asia Pacific as biosimilars are quite cheaper than biologics, hence it is expected to boost Asia Pacific Fabry disease treatment market growth. Fabry Disease Treatment Market Restraint Fabry disease is a very rare disease affecting around 1 individual in 50,000 (according to the National Fabry Disease Foundation), the diagnosis of Fabry disease is confirmed by demonstrating an enzyme deficiency in males and by identifying the specific GLA gene mutation in males and females. Hence, low diagnostic rate due to unavailability of such diagnostic procedures and trained professionals in emerging economies such as Africa, India, and China are expected to be major factor restraining global Fabry disease treatment market growth. Fabry Disease Treatment Market Key Players Key players operating in global Fabry disease treatment market include: Amicus Therapeutics Inc., Sanofi Genzyme (Sanofi S.A. company), Idorsia Pharmaceuticals Ltd., Protalix BioTherapeutics, Inc., AvroBio Inc., JCR Pharmaceuticals Co., Ltd., Resverlogix Corp, and Ozmosis Research Inc. Click To Reading More On Fabry Disease Treatment Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com (Added: Mon Feb 04 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Recombinant Cell Culture Supplements Market Trends, Industry Size, Growth, Opportunities - The technique of growing cells under controlled conditions, outside the natural environment is known as cell culture. Cells of interest are first isolated from living tissues, and then maintained in laboratory controlled conditions. The conditions for culturing varies; however, in most cases, a suitable vessel consisting of a medium or substrate, supplying gases, hormones, growth factors, essential nutrients such as minerals, carbohydrates, amino acids, and vitamins in a regulated physio-chemical environment is used. Cell culture provides essential insights regarding biochemistry and physiology of cells, which otherwise is difficult to understand in in vivo conditions. Moreover, these techniques assist in studying the effect of drugs on crucial factors such as population density, culture conditions, and growth rate. Media supplements or cell culture supplements play a vital role in assisting mammalian cells to produce proteins, which are the essential constituents of biologic drugs. Media supplements aid in regulating and customizing growth conditions for the cells, maintaining healthy cells for a longer duration, and improving growth and vitality of cells. Various factors are taken into consideration while adding culture supplements including state of addition (emulsion, solution, or powder), components of the supplement, and amount. Recombinant proteins have been extensively used in cell culture as supplements to boost consistency, productivity, and growth. The development of serum-free cell lines and culture media has been driven by the use of these recombinants. Read Report Overview: https://www.transparencymarketresearch.com/recombinant-cell-culture-supplements-market.html Rise in demand in cell culture projects for obtaining increased productivity drives the global recombinant cell culture supplements market. Moreover, increase in usage of animal-free supplements in the manufacture of vaccines, biopharmaceuticals, and stem cells contributes to the growth of the market. Added advantages of these supplements compared to conventional counterparts i.e., animal derived supplements, is projected to drive adoption of recombinant media in cell culture. Other factors fueling the growth of the global recombinant cell culture supplements market are rise in investment in life science R&D and increase in demand in the biotherapeutics industry. However, high cost associated with research in cell biology and consideration of several technicalities which are necessary for cell culture are expected to hamper the growth of the global market. The global recombinant cell culture supplements market can be segmented based on product and application. In terms of product, the market can be classified into recombinant transferrin, recombinant albumin, recombinant insulin, recombinant trypsin, recombinant epidermal growth factors, and recombinant aprotinin. Based on application, the global recombinant cell culture supplements market can be categorized into bioproduction, stem cells & regenerative medicine, and academics & research. In terms of region, the global recombinant cell culture supplements market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major share of the global market in terms of revenue in 2017. High growth of the market in the region can be attributed to increase in investments in R&D, presence of prominent biotherapeutics companies, and favorable rules and regulations put in place by the governmental bodies. Europe is a lucrative market for recombinant cell culture supplements in terms of revenue, followed by Asia Pacific. The market in Asia Pacific is expected to expand at a high CAGR during the forecast period. This can be attributed to surge in investments in life science research, increase in population, rise in the number of manufacturers of vaccines and other biopharmaceuticals in the region. Furthermore, increase in provisions from government bodies to support research and development of novel drugs and treatments is likely to propel the market in Asia Pacific during the forecast period. The market in Middle East & Africa and Latin America is projected to grow at a steady pace from 2018 to 2026 owing to rise in support from governments, increase in funding and investments in research projects, and improving economy. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57990 Key players operating in the global recombinant cell culture supplements market include Lonza, STEMCELL Technologies, Inc., PeproTech, Inc., Sino Biological, Inc., FUJIFILM Irvine Scientific, Evercyte GmbH, Kingfisher Biotech, Inc., Thermo Fisher Scientific, Inc., Novozymes, and Merck KGaA. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Feb 04 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Plasma Fractionation Market to Reach US$ 33,763.10 Mn by 2026 - Rising demand for plasma proteins, increasing investment in innovation and rising prevalence of rare diseases across the world are major factors that are expected to propel the global plasma fractionation market. The global market has been segmented based on product type, application, end-user, and region. Read Report Overview: https://www.transparencymarketresearch.com/plasma-fractionation-market.html The global plasma fractionation market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the plasma fractionation market. The global plasma fractionation market has been segmented based on product type, application, end-user and region. In terms of product type, the global plasma fractionation market has been classified into immunoglobulin, coagulation factor concentrates, albumin, protease inhibitors, and other plasma products. The immunoglobulin segment has been further sub-segmented into intravenous immunoglobulin and subcutaneous immunoglobulin. The coagulation factor concentrates segment factor VIII, factor IX, factor XIII, prothrombin complex concentrate, Von Willebrand factor and fibrinogen concentrates. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. In terms of application, the global plasma fractionation market has been segregated into neurology, immunology, hematology, critical care, pulmonology, and other applications. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=48600 In terms of end-user, the global market has been classified into hospitals and clinics, clinical research laboratories, and academic institutes. The segments have been analyzed based on health care infrastructure, government investment, and economic development in the regions. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. In terms of region, the global plasma fractionation market has been segmented into five major regions and the key countries in the respective region are: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, and Rest of Asia Pacific), Latin America (Mexico, Brazil, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions. The report also profiles the major players in the market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players operating in the global plasma fractionation market include . These players are adopting organic and inorganic growth strategies inorder to expand product offerings, strengthen geographical reach, increase customer base, and garner market share. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=48600 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Mon Feb 04 2019 Hits: 132 Rating: 0.00 Votes: 0) Rate It

• Pharmaceutical Waste Management Market is Driven by the Growth of the Pharmaceutical Industry - Pharmaceutical waste management is a critical issue across the world. In order to ensure safety from hazardous waste, several government organizations such as the Food and Drug Administration (FDA), the Environment Protection Agency (EPA), and the Drug Enforcement Administration (DEA) have introduced various programs for proper waste disposal. For instance, in April 2016, the Drug Enforcement Administration (DEA) hosted the 11th National Prescription Drug Take-back Day. The program was aimed at providing a safe and convenient means of disposal of unwanted, controlled substance prescription drugs. Read Report Overview: https://www.transparencymarketresearch.com/pharmaceutical-waste-management-market.html Factors such as rapidly growing health care sector in developed and developing economies, rise in research and development activities for the discovery of new pharmaceutical molecules for treatment of chronic diseases, and rapidly growing pharmaceutical industries across the world drive demand for pharmaceutical waste management. According to the Environmental Protection Agency (EPA), the U.S. is the leading producer of medical waste in the world. Increase in number of community pharmacies in Europe is expected to drive the pharmaceutical waste management market during the forecast period as all unused medication are returned to local community pharmacies for disposal. According to reports published in 2016, there are approximately 160,000 community pharmacies in Europe. The cost of pharmaceutical waste disposal in higher than the cost of manufacture in many developed and developing countries. Factors such as high cost required to build the facility, cost of land for dumping the waste, expensive waste collection vehicles, and equipment used for disposal of pharmaceutical waste restrain the growth of the pharmaceutical waste management market. In terms of revenue, the pharmaceutical waste management market in Asia Pacific is projected to expand at a CAGR of 5.9% during the forecast period. Rapidly aging population in the region is expected to boost demand for pharmaceuticals for the treatment of various diseases, which in turn is likely to fuel the growth of the pharmaceutical waste management market during the forecast period. According to the United Nations, China’s geriatric population is projected to double from 10% to 20% between 2017 and 2037, and estimated to reach 44% by 2050. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50181 The report also provides profiles of leading players operating in the global pharmaceutical waste management market. These include Stericycle, Waste Management, Inc., BioMedical Waste Solution, LLC, Daniels Health, Stryker, Covanta Holding Corporation, and Cardinal Health. Increase in merger & acquisition, strategic collaborations, and new product launches for pharmaceutical waste disposal are expected to drive the global market during the forecast period. On April 2017, Stryker announced the acquisition of Cactus, LLC, a manufacturer of Smart Sink, Pharma Lock, and Pharma Lock OR controlled substance waste management systems. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Feb 04 2019 Hits: 33 Rating: 0.00 Votes: 0) Rate It

• Gene Therapy Market is Driven by the Promising Therapeutic Outcomes of Gene Therapy - Gene therapy is a way of fixing genetic disorders by introducing a normal and healthy gene in place of defective genes in a cell in order to prevent or cure different types of genetic and chronic disorders for which no final cure has been developed. Gene therapy is considered as an important means of treatment, as it helps eliminate the usage of drugs, surgery, or other procedures that can have side-effects on the health of individuals. Moreover, gene therapy results in the formation of beneficial proteins that can help the body perform normal functions to its full potential. Cell-based technologies have been developing at a rapid pace, which in turn has driven the demand for gene therapy. Till date, only five gene therapy products have been approved and are currently in the infancy stage of commercialization. Gendicine was the first commercialized gene therapy product developed by the Shenzhen, China-based SiBiono GeneTech, in 2003. Gendicine was commercialized in China, in 2004. Read Report Overview: https://www.transparencymarketresearch.com/gene-therapy-market.html The global market for gene therapy has been expanding due to the intensive research that has offset in the domain of genetics. Demand for gene therapy across the globe has increased significantly due to the rise in awareness about the ability of gene therapy to cure diseases. Gene therapy has considerable potential to eliminate and prevent several genetic disorders and numerous life-threatening disorders, especially cancer, heart diseases, AIDS, cystic fibrosis, and age-related disorders. Gene therapy provides a complete cure to patients affected with genetic disorders, rather than ease symptoms with other therapeutic treatments. Promising therapeutic outcomes and increasing competition among leading biopharmaceutical companies to approve and commercialize gene therapy products in different areas of unmet medical needs, in order to gain the first mover advantage, are projected to boost the gene therapy market during the forecast period. Moreover, high prevalence and rise in incidence rates of different types of cancers for which complete cure has not been developed is a key factor that is expected to drive the gene therapy market. Large number of gene therapy candidates are in late stage clinical studies and are anticipated to commercialize during the forecast period. Significant investments in the field of gene-related research and development by various biopharmaceutical companies, governments, as well as research institutes offers potential opportunity to gain the first mover advantage in the gene therapy market. According to Alliance for Regenerative Medicine, in 2015, more than US$ 10 Bn has been invested by both public as well as private companies in gene therapy-related research. Companies, after initial success rates of gene therapy, are striving to increase the number of treatment centers in order to increase the access to a large number of patient pool requiring gene therapy treatments. Thus, increasing number of gene therapy treatment centers in developed countries offers significant opportunity to global players operating in the gene therapy market. The global gene therapy market has been segmented based on product, application, and region. In terms of product, there are only five gene therapy products that have been approved and commercialized globally. These include Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine. The Yescarta segment dominated the global market in 2017. It is projected to gain market share by the end of 2026. Yescarta bagged the first mover advantage in 2017 in the U.S, by launching the first CAR T therapy approved by the US FDA for the treatment of certain relapsed or refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL). Furthermore, high prevalence of DLBCL and anticipated commercialization of Yescarta in Europe and other developed countries are projected to drive the demand for Yescarta during the forecast period. The Luxturna segment is projected to expand at a significant growth rate during the forecast period. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1838 Based on application, the global gene therapy market has been divided into ophthalmology, oncology, and adenosine deaminase ?deficient severe combined immunodeficiency (ADA-SCID). The oncology segment accounted for a prominent share of the market in 2017. Of the five gene therapy products approved, three products are directed toward the treatment of certain forms of cancer. Moreover, increased application of gene therapy products in treatment of other forms of cancers is poised to drive the oncology segment during the forecast period. Based on region, the global gene therapy market has been segmented into three major regions: U.S., Europe, and Rest of World. Europe is projected to account for a dominant share of more than 40% of the global market by 2026. Increasing number of gene therapy treatment centers in the region and high prevalence and rising incidence rates of non-Hodgkin lymphoma are projected to fuel the gene therapy market in the region during the forecast period. The U.S. is projected to follow Europe, in terms of share of global gene therapy market, by the end of 2026. It is estimated that in the U.S., every year, around 7,500 patients with refractory DLBCL are eligible for CART therapy. The gene therapy market in Rest of World is projected to expand at a notable CAGR during the forecast period. In 2003, Gendicine was approved in China and was commercialized in 2004. Since then, more than 30,000 patients with head and neck cancers have been treated with Gendicine, in China. The anticipated approval and launch of gene therapy products in developed countries, such as Japan, Australia & New Zealand, and GCC is projected to drive the gene therapy market in this region. Majority of biopharmaceutical companies have made significant investments in the clinical research and development of gene therapy products. According to a report by the Alliance for Regenerative Medicine, there were around 34 gene therapy candidates in phase III clinical trials as of June 2017. Key players operating in the global market include Gilead Sciences, Inc., Novartis AG, Sibiono GeneTech Co. Ltd., Spark Therapeutics, Inc., CELGENE CORPORATION, and Orchard Therapeutics Limited. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1838 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Mon Feb 04 2019 Hits: 128 Rating: 0.00 Votes: 0) Rate It

• Hematocrit Test Devices Market: Rise in Technological Advancement to Boost the Growth - Hematocrit test devices are type of in vitro diagnostic devices. These devices are computerized and specialized machines used for counting and characterizing white blood cells, platelets, and red blood cells. New generation hematocrit test devices are bench top and have micro sampling autoloaders with continuous loading capability. Additionally, these are equipped with barcode tracking technology. Moreover, point-of-care hematocrit test meter is a wireless instrument that operates on a single-use cartridge. Normal blood analyzers can complete blood count analysis with three-level WBC differentiation. The three major physical technologies used in blood analyzers are electrical impedance, flow cytometry, and fluorescent flow cytometry. The device has gained popularity, as it helps in effective evaluation of hematocrit value compared to manual method for evaluation of hematocrit parameter. Rise in blood-related diseases among the geriatric population is likely to drive the global hematocrit test devices market in the near future. Read Report Overview: https://www.transparencymarketresearch.com/hematocrit-test-market.html The global hematocrit test devices market is characterized by increase in incidence of chronic disease induced anemia across the world. The market is witnessing gradual rise in technological advancement supported by government funding and initiatives. The global hematocrit test devices market is projected to expand at steady pace from 2018 to 2026. Increase in the geriatric population which is prone to blood borne diseases, large patient base in developing countries demanding proper treatment and diagnosis, and investments by public and private market players in R&D on hematocrit test devices for diagnostic testing of blood and treatment of hematology originated diseases drive the global hematocrit test devices market. However, lengthy regulatory approval procedure, significant investment required in innovation of diagnostic devices and solutions, and lack of awareness about importance of hematocrit tests in the diagnosis of diseases are likely to restrain the global market during the forecast period. Hematocrit test devices are gaining popularity among health care professionals, as these have proven to be effective in producing accurate complete blood count result which help health care professional in the treatment and diagnosis of blood borne diseases. Use of hematocrit test devices reduces the inaccurate evaluation of hematocrit value using manual calculation and are found to be more effective in complete blood count test than laboratory based manual procedures. Investment in innovation in hematocrit test meters or analyzers and partnerships for co-development and commercialization of hematocrit test devices are expected to fuel the growth of the global hematocrit test devices market in the near future. In terms of product, the global hematocrit test devices market has been classified into blood analyzers, hematocrit test meters, and others. The others segment comprises consumables and accessories of hematocrit test devices. The blood analyzers segment includes hematology analyzers and blood gas systems. The blood analyzers segment is projected to dominate the market during the forecast period. Growth of the segment can be attributed to increase in usage of blood analyzers for various tests such as white blood cell count, reticulocytes analysis, and coagulation test complete blood count test, as these devices are easy to use, provide high level of precision and accuracy for red blood cell counting for evaluation of hematocrit parameters of individuals. Moreover, presence of key companies such as Sysmex Corporation and F. Hoffmann-La Roche Ltd. engaged in research & development and manufacture of innovative blood analyzers boosts the growth of the global market. Furthermore, initiatives taken by public and private organizations are aimed at installing new generation blood analyzers to provide better healthcare facilities and patient care. The relatively stable growth rate of the segment can be ascribed to high replacement rate and limited pipeline of blood analyzers. The hematocrit test meters segment is anticipated to expand at an above average growth rate during the forecast period despite the predominant use of blood analyzers in hematology testing. Preference for hematocrit test meters for hematocrit testing has increased among physicians and other end-users, as these are point-of-care devices and have the potential to provide decentralized patient care and hematocrit test at bedside and faster results than blood analyzers. Additionally, launch of products by Abbott, Nova Biomedical, and EKF Diagnostics are likely to drive the hematocrit test meters segment during the forecast period. Based on end-user, the global hematocrit test devices market has been classified into hospitals & ambulatory surgical centers, clinics, diagnostic & pathology labs, and others. The hospitals and ambulatory surgical centers segment is expected to dominate the global hematocrit test devices market during the forecast period. In terms of region, the global hematocrit test devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major share of the global hematocrit test devices market in 2017. Europe was another major market for hematocrit test devices in 2017. Developed health care infrastructure and relatively high paying capacity of patients in North America and Europe compared to the developing countries provide assured business growth to new market entrants, which contributed to the high market share of these two regions. High growth rate of the diagnostic industry in India and China and investment made by global companies in China for establishment of sales subsidiaries for providing support and services to customers and to attract new potential customers are expected to propel the hematocrit test devices market in Asia Pacific. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50298 Major players operating in the global hematocrit test devices market include Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthineers (Siemens AG), EKF Diagnostics Holdings plc, Sysmex Corporation, Nova Biomedical, Abbott Laboratories, HORIBA, Ltd., and Boule Diagnostics. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Mon Feb 04 2019 Hits: 133 Rating: 0.00 Votes: 0) Rate It

• Dual Specificity Protein Kinase TTK Market - Report 2018-2026 Focuses On Top Companies - Protein kinase are critical regulators of diverse cellular functions and are widely known for their high affinity towards targets in a variety of pathological conditions. The pharmacology of kinase inhibitors have tremendously developed over the past two decades, facilitating most of the inhibitors to be available orally. This gene is associated with cell proliferation, and is essential for chromosome orientation at the centromere during mitosis and is required for centrosome duplication. It is found to be a critical mitotic checkpoint protein for accurate segregation of chromosomes during mitosis. They have high utility as a therapeutic target in various application areas such as breast cancer, metastatic breast cancer, solid tumor, colorectal cancer, prostate cancer, pancreatic ductal adenocarcinoma, and others. Dual Specificity Protein Kinase TTK Market – Dynamics Increasing prevalence of various types of cancers such as breast cancer, metastatic breast cancer, solid tumor, colorectal cancer, prostate cancer, pancreatic ductal adenocarcinoma, and others is expected to contribute to significant growth of the dual specificity protein kinase TTK market. For instance, according to the Cancer Research UK, it is projected that around 17 million new cases of cancer will be registered across the globe in 2018. Moreover, as per the U.S. National Library of Medicine and National Institutes of Health, pancreatic ductal adenocarcinoma is one of the most lethal cancers worldwide with the highest incidence rates found in North America and in Western Europe while lower rates in Asian Africa, with the incidence rates of 7.2 and 2.8 per 100,000 populations, respectively in 2017. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2373 Increasing number of pipeline molecules of dual specificity protein kinase TTK as a targeted therapy for various types of cancer is expected to propel growth of the dual specificity protein kinase TTK market. The pipeline dual specificity protein kinase TTK constitutes around 10-12 molecules, out of which around 7 molecules are developed by companies and others by the universities/institutes. For instance, in 2017, Bayer AG completed phase I trial studies for its pipeline molecule Empesertib (BAY 1161909) in solid tumors in the U.S. Furthermore, increasing investment by pharmaceutical companies has influenced growth of the market. Dual Specificity Protein Kinase TTK Market – Regional Insights On the basis of region, the global dual specificity protein kinase TTK market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America held dominant position in the global dual specificity protein kinase TTK market in 2017. This is owing to increasing research and development activities in oncology segment in the region. Moreover, rising incidence of various types of cancers is expected to propel growth of the market in this region. For instance, according to American Cancer Society, in 2017, around 13% of all the cancers diagnosed in adults aged 20 and above are rare cancers with the incidence of around 6 cases per 100,000 people per year. Moreover, Asia pacific is expected to witness significant growth in the dual specificity protein kinase TTK market over the forecast period, owing to increasing R&D activities for cancer-based targeted therapies and government initiatives for cancer awareness in the region. For instance, in Australia, a non-profit organization called Rare Cancers Australia (RCA) is committed to improve the lives of patients with rare and less common cancers by promoting the significance of early diagnosis and increasing treatment options for the Australian population. Dual Specificity Protein Kinase TTK Market – Competitive Landscape Major players operating in the dual specificity protein kinase TTK market include Bayer AG, Boston Pharmaceuticals, Les Laboratoires Servier SAS, Nerviano Medical Sciences Srl, Netherlands Translational Research Center BV, and Pfizer Inc. Key players are focused on adopting market strategies such as new product developments and clinical trial approvals, in order to retain dominant position in the market. For instance, in September 2015, Servier and Nerviano Medical Sciences started their first in human clinical trial of the drug S 81694 (NMS-P153). This drug is an inhibitor of the mitotic checkpoint kinase MPS1. Click To Reading More On Dual Specificity Protein Kinase TTK Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. (Added: Mon Feb 04 2019 Hits: 63 Rating: 0.00 Votes: 0) Rate It

• Healthcare Analytics Market – Allscripts acquire Practice Fusion - Recent Developments Allscripts Healthcare Solutions, Inc. is a widely merchandised American organization that provides the practice management and electronic health record technology to the hospitals, physician practices, and other healthcare providers. In January 2018 – All scripts Healthcare Solutions, Inc. had publicized a definitive agreement to get Practice Fusion. In October 2017 – The All scripts Healthcare Solutions, Inc. Had to get the McKesson’s Enterprise Information Solutions business. To know more, read: https://www.marketdataforecast.com/market-reports/healthcare-analytics-market-45/ Market Segmentation: Market Data Forecast published a report named Healthcare Analytics Market. Global Healthcare analytics market is estimated at $8.93 Billion in 2018 and is poised to reach $27.7 Billion by 2023 at a CAGR of 25.41%. Report segmented as: Type: • Predictive Analytics • Descriptive/Retrospective Analytics • Prescriptive Analytics Application: • Financial Analytics • Clinical Analytics • Operational & Administrative Analytics Amongst end users, the health care providers sector is except to rise at the highest CAGR during the forecast period. Federal mandates, for instance, the execution of EHRs and ICD-10 code sets, swing in the direction of value-based medicine, and the amplified focus on quality care and lessen the costs are propelling the development of this sector. Geographical Segmentation: Based on geography, the market is analyzed under several countries namely, North America, Latin America, Asia-Pacific, Middle East, and Africa and Europe. Europe is dominating the Healthcare Analytics Market and Asia-pacific approximated to grow at the highest rate. Key Market Players: • IBM Corporation • Cerner Corporation • Optum, Inc. • Verisk Analytics, Inc. • Truven Health Analytics Inc. View a sample and decide: https://www.marketdataforecast.com/market-reports/healthcare-analytics-market-45/request-sample The Scope of the Report: The report offers a comprehensive examination of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in influencing the market dynamics and trends discussed in detail at the product level. Further, the performance of the market at the regional and country-level had assessed and the prospects with huge growth potential identified and debated. The key players in the industry are profiled giving insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry had provided. The report also provides a broad outlook of the current market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: Market Data Forecast™ Address: Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626 (Added: Mon Feb 04 2019 Hits: 26 Rating: 0.00 Votes: 0) Rate It

• Mental Health Software Market - Recent Developments Cerner Corporation is a supplier of health information technology solutions, services, devices, and hardware. EHR and HealtheIntent are Cerner’s clients. Cerner recognized its clients for receiving the CHIME weirdest designation. The company focuses on improving the delivery of care. It is devoted to improving the quality of life for the people. Remi Vista Selects Cerner for Improved Behavioral Health Care Delivery. To know more, read: https://www.marketdataforecast.com/market-reports/mental-health-software-market-6154/ Market Segmentation Market Data Forecast published a report named Mental Health Software market. It is worth USD 1.36 billion in 2018 and estimated to be growing at a CAGR of 13.87%, to reach USD 2.6 billion by 2023. Report segmented as: Delivery mode: • Subscription models • Ownership models End User: • Hospitals • Community clinics • Private practices • Residential • Payers Based on the delivery mode, the subscription model has the largest share. Under the end user, hospitals lead the market under this segment. Geographical Segmentation The Global Mental Health Software market is divided based on geography into North America, Latin America, Asia-Pacific, Middle East, and Africa and Europe. North America has the leading market for Mental Health Software in the world. Key Market Players: • Cerner Corporation (U.S.) • Core Solutions (U.S.) • Credible Behavioral Health (U.S,) • MindLinc (U.S.) View a sample and decide: https://www.marketdataforecast.com/market-reports/mental-health-software-market-6154/request-sample The scope of the report: The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated. The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis of prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook on the market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: Market Data Forecast™ Address: Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626 (Added: Mon Feb 04 2019 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• Neurointerventional Devices Market Research - Future Market Insights (FMI), in its latest report titled, “Neurointerventional Devices Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025”, has projected global neurointerventional devices market to expand at a CAGR of 4.8% during the forecast period (2015-2025). As per the Society of Neurointerventional Surgery, neurointervention is a treatment approach to conditions occurring within the blood vessels of the brain or in the spinal cavity. This procedure is highly performed by neuro-specialists due to its safety, minimally-invasive technique and comparatively higher success rate ratio as compared to conventional clipping method. Global neurointerventional devices market is estimated to account for US$ 1,766.8 Mn by the end of 2015, mainly driven by rising demand from end-use segments. The report analyses the global neurointerventional devices market in terms of market value (US$ Mn) and market volume (units) by product type, region, end-user and technique, and provides information regarding market dynamics, regulatory compliances, competitive landscape, current trends, market estimations and forecast for the market. Adoption rate of neurointervention devices among neurosurgeons/neuro-specialists has increased significantly owing to the technological advancements and benefits these devices offer. These devices, especially metal coils and catheters, are highly preferred by neurosurgeons. Increasing geriatric population globally is also expected to boost overall demand for neurointerventional devices. These devices find wide application in Japan and countries in developed regions such as Western Europe and North America. However, these devices are expected to gain popularity in Latin America and Asia Pacific excluding Japan (APEJ) in the near future. High cost along with negative perception about certain neurointervention devices are factors that are expected to act as growth restraints in the future, and some devices approval by FDA have also faced criticism for performance. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-871 North America is expected to dominate the global market throughout 2025 and is projected to witness 1.6X increase in volume over the forecast period. The U.S is expected to dominate the North America neurointerventional devices market throughout the forecast period. However, the U.S. market is projected to lose significant amount of its market value share to Canada by the end of forecast period. North America is a major neurovascular market. The region is expected to witness launch of various new products, with increasing number of players expected to enter into the market over the following five years. Japan is the next most lucrative market for neurovascular companies; however, the market in the region is projected to witness below average CAGR of 3.9% during the forecast period. Among product types, embolic coils product segment is expected to dominate the global neurointerventional devices market, followed by the neurothrombectomy product segment. Increasing incidence of brain aneurysm is expected to boost overall demand for embolic coils albeit, at a comparatively lower pace. Flow diverters and stent retrievers are gaining wide recognition among neurointerventionists. Stent retrievers segment is expected to witness impressive growth in the U.S. market over the following five years. Global stent retrievers segment is expected to witness 2X increase in value over the forecast period. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-871 On the basis of technique, neurointervention devices market is segmented into neurothrombectomy procedure, cerebral angiography, stenting, coiling procedures and flow disruption. Coiling procedure segment is expected to dominate the overall neurointerventional devices market by the end of forecast period. The segment is projected to register average growth rate over the forecast period. Flow disruption is projected to be the fastest growing procedure segment. Increasing adoption of flow diverters among neurointervention is fuelling growth of the procedure segment. On the basis of end use, the market has been segmented into hospitals and ambulatory surgical centers. Hospitals segment accounts for major share of the neurointerventional devices market. Key market participants covered in the report include Medtronic, Penumbra Inc., Stryker Corporation, Terumo Corporation, and Johnson & Johnson.  ^pop (Added: Mon Feb 04 2019 Hits: 147 Rating: 0.00 Votes: 0) Rate It

• Revenue Analysis of Immunodiagnostic And Clinical Chemistry Market Forecasts 2019-2023 - Market Reports on China Provides the Trending Market Research Report on “2019-2023 China Immunodiagnostic Market: Supplier Shares and Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review” under Diagnostics Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports. This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts, compares features of leading analyzers, profiles key competitors, and identifies specific product and marketing opportunities emerging during the next five years. Request a free sample copy of Immunodiagnostic Market Report @ http://www.marketreportsonchina.com/marketreports/Sample/Reports/1354955 This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts, compares features of leading analyzers, profiles key competitors, and identifies specific product and marketing opportunities emerging during the next five years. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations, advances in diagnostic technologies, system engineering, automation, and IT, and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators. Tests Analyzed in the Report: Routine Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid. Therapeutic Drug Monitoring (TDM) Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin. Endocrine Function Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, PO Ab, TSH. Tumor Markers and Special Chemistry AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12. Immunoproteins C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis. Drugs of Abuse Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants. Current and Emerging Products - Analysis of current and emerging clinical chemistry and immunodiagnostic tests. - Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers. Technology Assessment - Assessment of current and emerging technologies, and their potential market applications. - Comprehensive lists of companies developing or marketing new technologies and products by test. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Competitive Assessments - Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. Browse our full report with Table of Contents: http://www.marketreportsonchina.com/marketreports/2019-2023-china-immunodiagnostic-market-supplier-shares-and-strategies-volume-and-sales-forecasts-technology-and-instrum/1354955 About Market Reports on China: Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China. We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market. Contact us: Market Reports on China Tel: +91 22 27810772 / 27810773 Email: info@marketreportsonchina.com Website: http://www.marketreportsonchina.com  ^pop (Added: Mon Feb 04 2019 Hits: 97 Rating: 0.00 Votes: 0) Rate It

• Ways to keep our bones & joints Healthy at sharrets nutrition - For Immediate Release Sharrets Nutrition LLP www.sharrets.in 31 January 2019, Jaipur, India. With our growing age, taking care of your bones and joints becomes an important a part of our life. If avoided, initially it affects our quality and any restricts ourselves from doing routine tasks. Though the Almighty has given our body a capability of self-repair however our joints and bones enkindle additional care and a spotlight. Factors inflicting weak bones and stiff joints Here square measure a number of caused highlighted below that result into low bone density and stiffer joints: 1. Associate in nursing inactive and lazy life-style 2. Secretion imbalance 3. Loss of bone calcium and different very important minerals 4. Loss of secretion gift in joints causes stiffness and non-flexibility in joints. Ways to realize ideal bone and joints health 1. Feeding fruits and veggies: Vegetables being a good supply of water-soluble vitamin stimulate the formation of cells that square measure accountable for bone production and strengthening. Also, the antioxidants stop damaging of bone cells. In taking vegetables and fruits during a higher quantity increase mineralization of your bones. 2. Exercising: Letting yourself engaged in weight bearing and strength building exercises can assist you to realize ideal bone mass. It enhances bone density and conjointly checks inflammation and markers thanks to bone turnover. For joints, muscle strengthening exercises will do wonders. Besides, quality movements of joints for five to ten minutes daily will take away stiffness in your joints. 3. Intense protein: For having healthier bones, it's necessary to follow wealthy macromolecule diet. Foods that square measure wealthy in macromolecule enable Ca to be absorbed by the bones simply whereas if your diet lacks protein-rich food you're probably to own fracture-prone weak bones. 4. Feeding high Calcium all day: Calcium is that the basic mineral found in your bones. Thus, you want to unfold calcium intake throughout the complete day. A traditional person desires one thousand mg of calcium during a day. It's 1300 mg for teenagers and 1200 mg for older girls. 5. Intake of useful fats: The fat we have a tendency to take daily works to encapsulate and populate cell membranes. It becomes essential to intake useful fats like avocado, flax seeds, balmy and dry fruits, and fatty fish likewise salmon for the nourishment of our body. Omega three fatty acids facilitate to fight inflammation within the body. They’re gift in linseed and salmon. Hence, acquire these useful tips for obtaining healthy bones and joints to steer a lively life. About Sharrets Nutrition LLP “SHARRETS” the brand develop to deliver only highest quality dietary health supplements and health foods at the best value. The company have a commitment and dedication to deliver best quality skincare, health, nutrition, supplements and dietary products at competitive price with quality promise. Offer compressive range of health products from vitamins and minerals, organic produces, sport nutrition to body and beauty supplement. (Added: Mon Feb 04 2019 Hits: 17 Rating: 0.00 Votes: 0) Rate It

• Unearthing the Advancements in Neurodegenerative Diseases - PULSUS group cordially welcomes researchers, academicians, students and business professionals in the field of Neurodegenerative Diseases around the world to participate in the “2nd International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” on June 10-11, 2019 at Dublin, Ireland. The theme of the conference is “Unearthing the Advancements in Neurodegenerative Diseases”. Alzheimers 2019 Conference is on June 10-11, 2019 at Dublin, Ireland with theme “Unearthing the Advancements in Neurodegenerative Diseases”.The two-day meeting is going to be an event to look forward for its enlightening symposiums & workshops from established experts in Alzheimer's Disease, Dementia and many other related Neurodegenerative Diseases, potential keynote talks from eminent speakers, informative oral sessions and innovative poster presentations.  ^pop (Added: Mon Feb 04 2019 Hits: 113 Rating: 0.00 Votes: 0) Rate It

• Dr. Amod Manocha, the Best Pain Specialist in Delhi – Removing Pain and Restoring Fulfilled Life - Algiatry is the medicine branch taking the interdisciplinary approach to alleviate pain. In other terms, they are pain medicine, pain control and pain management aimed at reducing physical pain related suffering and improving the life quality of those in chronic pain due to a number of medical conditions and diseases. This branch of medicine is getting a lot of attention in recent years and the field is developing as more and more pain management experts emerge. One of them is Dr. Amod Manocha, a trained pain management specialist and anesthetist. He is the best pain specialist in Delhi and his 13 years of work experience in the United Kingdom fortifies his repertoire. Dr. Amod Manocha offers neuropathic pain treatment in Delhi, among others. He had worked as a chronic pain consultant in many hospitals across the United Kingdom. Now, he is a pain specialist in Delhi, working to solve pain-related issues his patients face that make them unable to function at optimum levels. Pain can occur due to a number of causal factors, injuries, diseases, and nutrient deficiency as well as congenital defects. It’s important to establish the causes that trigger pain and Dr. Amod Manocha’s cognizance in this interdisciplinary medicine makes him an outstanding pain specialist doctor in Delhi. With his professional knowledge about pain and the connected medical factors, Dr. Amod Manocha is the best pain specialist in Delhi. Dr. Amod Manocha is a Senior Consultant and Head of Pain Management Services at Max Multispecialty Hospital, Saket. In the field of pain management, he adheres to globally set standards and is passionate about evidence-based treatments. Pain medicine and pain control are not a one-time visit to the doctor, make the diagnosis and collect the painkillers. It needs recurring meetings and follow-ups. Hence, building a relationship between doctor and patient is indispensable, often, long-term. Dr. Amod Manocha closely adheres to those principles of pain management medicine. Keeping the patients’ wellbeing and their best interests at heart, Dr. Amod Manocha is dedicated to providing quality healthcare that augments a patient’s life quality. (Added: Mon Feb 04 2019 Hits: 64 Rating: 0.00 Votes: 0) Rate It

• International Conference on Pediatric Healthcare - Pediatric Healthcare 2019 to be held at Prague, Czech Republic amid June 12-13, 2019. This International Conference on Pediatrics Healthcare is a unique platform to share the knowledge on current research. The main aim of Pediatric Healthcare 2019 is to discuss the recent approaches/advancements and challenges faced in relevant to child healthcare and medicine. Without a doubt the member at this Pediatric Healthcare Conference will have the capacity to trade with the best specialists in the strength and will return home with the broad learning.  ^pop (Added: Mon Feb 04 2019 Hits: 117 Rating: 0.00 Votes: 0) Rate It

• Alcoholics Anonymous "Big Book" Reveals Deep Truth About Alcoholism - Florida, USA – With the launch of the Big Book, it is expected that alcoholics and addicts are going to get a lot of help by learning how to become sober and why they shouldn’t make alcohol the first choice in their life. Those who are new to Alcoholics Anonymous will get to understand how unique this book is. It has been published in a step-by-step manner so people who need guidance to get away from alcohol can read the book and implement the lessons in their personal life. The first part of the book, particularly the first 164 pages, deals with how one can achieve sobriety. One of the best things about the Big Book is Amethyst Recovery Center has released a reading guide for every chapter. When an alcoholic is reading the book for the first time or if he/she is new to Alcoholics Anonymous, it can be easier to understand the book. Since the first part is about how to achieve sobriety, it is important that the readers pay attention to every chapter. The eleventh chapter of the book is called "A Vision for You" (Learn more about it here).It deals with what the vision of an addict or an alcoholic could be when he or she achieves sobriety. The chapter is a silver lining for those who can’t think of anything apart from drinking. It is a chapter that can help a person come to the same conclusion as others who have achieved sobriety. There are numerous stories from alcoholics who came out clean. They have shared their experiences that will be helpful for the people who are reading the book for the first time and want to come out of their addiction for good. There is an integral part of the book called “There is a Solution” where the method of recovery have been clearly written down. Even people who do not have any religious beliefs will be guided into a path of spirituality after they have finished reading the book. The fact that the Big Book is divided into easy chapters is what makes it so unique. From the twelfth chapter onwards, readers will be able to learn how they can attain spirituality and what impact it will have on their life. There are chapters where readers can learn about working with others and why it is essential to permanently overcome alcoholism. Overall, the Big Book is going to be a benefit to those who are eager to become sober. It is a well-written book that is not just a guide to leading a sober life, but it also gives an insight on people who have already come out clean. About Amethyst Recovery Center: Recovering from alcohol or drug addiction can be tough, but Amethyst Recovery Center provides resources that may be able to help. With Alcoholics Anonymous, they have laid a foundation to make sure that addicts and alcoholics find a way to get back from despair and lead a normal life like the others.  ^pop (Added: Mon Feb 04 2019 Hits: 114 Rating: 0.00 Votes: 0) Rate It

• Secure Your Health With Policy21st Health Insurance - Health is the most fragile thing that we all have and it should be taken very seriously so that no health emergency can disturb us. It is thus, of utmost importance to know about various ways in which we all can protect our health and our pockets from any undue emergency. A health insurance policy is the best method that insures our health and those of whom we love. Unlike travel or term insurance policies, a health insurance policy is one best things that one should invest in during these days. The medical inflation that grows approximately 10% annually is making it difficult for many to avail the benefits of health care facilities that have developed, providing the best health in case for various deadly diseases. A health insurance policy makes it feasible for people of all ages of the society to insure their health. Understanding the need to secure the health of the individuals of the country, the government has made sure that there are schemes offered by policy providers specially for senior citizens, who are the higher risks of contracting critical illnesses that require treatments and procedure costing millions. Also, there is also a good news for the medical people because there are plans such as the health insurance premium plan, which with the help of the premium calculator that compares various policies and decide the premium based on your requirements so that you do not pay more than what you require. Now the question comes that are we going to buy a different plan for each of the members of the family? wouldn’t that be much confusing and difficult task to remember the policy dates, dates when premiums are o be filled etc,? Not with the family floater plans offer you a lot benefits, the most important being that it is just plan that can take care of all the health care needs of different members of the family. You can add up to 15 members of your family to this plan which include you, your spouse, your kids, your parents, your in laws etc. As for the benefits these plans are concerned, you stay assured that your overall covered by these policies. Pre, post and hospitalisation charges which include hospital bills, bills of medicine, drugs, room rent, ambulance charges etc are taken care of by it. Your daily care procedures, critical illnesses, the expenses of the organ donor etc get covered by your health insurance policy. For a family floater plan, one must check the eligibility criteria of both the youngest and the eldest of the members in the plan. Also, it has to be noted that a family floater plan ceases to exist once the eldest member reaches the maturity age. However, you can add new members to the existing plan while the policy is still working by an addition of the premium too. The difficulty of choosing from among various plans available has also been eased out because now a days, you get a health insurance policy compare on line, which is available on line. Compare different policies which is a lot more easy as it provides with reviews from plan provider and various customers, saves your time and is much more effective because it doesn’t involve talking with agents etc. A health insurance policy has a lot to offer and has also been made feasible and achievable for a lot of people. It is not only a luxury but also a necessity. It is, however, suggested that you go through the terms and conditions of each policy, check what all are the inclusions and exclusions of the policy are, before you finally settle for any. Also Remember that Comparison is the key. For More Information Visit Here :- https://www.policy21st.com/best-health-insurance-policy-in-india Contact Person :- Jeetu Gupta Address :- KH-192/G 9, 25 FUTTA ROAD MUKUNDPUR EXT. PART 2 NEW DELHI-110042 Business Gmail id:- info@policy21st.com Contact Number :- 9555620725 (Added: Sat Feb 02 2019 Hits: 28 Rating: 0.00 Votes: 0) Rate It

• Success Rate of Non Melanoma Skin Cancer Surgery - 25 Nov 2018: India in recent times has got recognition in the world as a global destination for getting high-quality healthcare services at affordable cost. The difference in cost when compared to the highly developed nations' hospital but the availability of similar quality cancer care has made all the difference. The Cost Difference when it comes to the skin cancer surgery India is huge when it comes to availing healthcare services in Indian hospitals. With huge investment taking place in the healthcare domain getting high-quality cancer has become possible. But as we know India has been traditionally known to cater to low cost and affordable cost healthcare services, it has gained recognition in the world for global patients. The Non-Melanoma Skin Cancer is a kind of Skin cancer is something that relates to cancer cells found in the skin at any body part. It starts with a malignant growth in a group and keeps on destroying the neighboring tissues. It metastatic in nature, which means it can spread to any other body part, but this is rare. Mostly the UV rays coming from the sun is the cause behind this kind of cancer. It can be on the hand, face or anything, which is nothing but the abnormal development of cells bringing out the dreaded ailment in the human body. As per healthcare reports, the menace has increased in recent times, but timely action in the form of a proper treatment has made all the difference in curbing the dreaded disease. Skin cancer, therefore, is no more an ailment that can be cared a lot. The high-end infrastructure of the hospitals and clinics that offer the best possible cancer care facilities, which are backed with competitive costs. Even if you seek the help of top doctors and Surgeons in this country, you still get affordable cancer care services. The Best Facilities and Features available at the cancer hospitals are known to have one of the best features and facilities, which are backed with state of art technology and offers high-quality healthcare services. The modern machines and equipment placed in the hospitals have been playing a key role in fixing the ailments right on time and with great professionalism and competence of the cancer surgeons and experts. India now has become the fifth most preferred destination as per the recent medical tourism reports in the world. The success rate Non-Melanoma Skin Cancer Surgery in India is an all-time high. About India Cancer Surgery Site - If there is any medical tourism group that specializes in cancer care, then it is India Cancer Surgery Site. The medical consultants have ranked high when it comes to offering high-quality cancer care services to global patients at affordable cost. The company has the best of the cancer surgeons and experts in their network and they offer you the best of the cancer care backed with affordability elements. They serve global patients in many directions including local travel, food and many more things that you can think of while getting a global destination for quality healthcare services. For more on India Cancer Surgery Site Visit the site - https://www.indiacancersurgerysite.com/best-price-skin-cancer-treatment-surgeons-hospitals-india.html P1, B-162, Princeton Estate DLF City Phase-V, DLF Phase 5, Sector 55, Gurugram, Haryana - 122002 India Phone no - 9371770341 Email - info@indiacancersurgerysite.com (Added: Sat Feb 02 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• AVASCULAR NECROSIS OF HIP - Hip pain is one of the most common types of pain in the world. It causes due to various problems with hip muscles, ligaments, tendons and other soft tissues surrounding the hip. Avascular Necrosis (AVN) is commonly occurs in the Hip. Bone is a living tissue hence it requires blood. In Avascular Necrosis (AVN), bone tissue dies due to a lack of blood supply. If this problem is not treated on time then it can lead to tiny breaks in the bone and finally causes bone to collapse. Avascular Necrosis (AVN) is also known as Osteonecrosis, Aseptic Necrosis or Ischemic Bone Necrosis. People between the age group of 30-50 are mostly affected by Avascular Necrosis disease. (Added: Sat Feb 02 2019 Hits: 34 Rating: 0.00 Votes: 0) Rate It

• Global Dental Implant Market Forecast And Analysis 2016-2021 - Summary: This report provides detailed analysis of worldwide markets for Dental Implant from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological And market trends within the implant market and more lays out an analysis of the factors influencing the supply/demand for implant, and the opportunities/challenges faced by industry participants. It additionally acts as a vital tool to firms active across the worth chain and to the new entrants by sanctionative them to capitalize the opportunities and develop business ways. A implant (also referred to as AN endosseous implant or fixture) may be a surgical element that interfaces with the bone of the jaw or os to support a dental prosthesis like a crown, bridge, denture, facial prosthetic device or to act as AN dental medicine anchor. The basis for contemporary dental implants may be a life method known as osseointegration wherever materials, like metal, form an intimate bond to bone. The implant fixture is 1st placed, so it's doubtless to osseointegrate, then a dental prosthetic is added. A variable quantity of healing time is needed for osseointegration before either the dental prosthetic (a tooth, bridge or denture) is hooked up to the implant or AN abutment is placed which will hold a dental prosthetic. Success or failure of implants depends on the health of the person receiving it, medicine that impact the probabilities of osseointegration and also the health of the tissues within the mouth. The amount of stress that may be placed on the implant and fixture throughout traditional operate is additionally evaluated. Planning the position and range of implants is essential to the semipermanent health of the prosthetic since biomechanical forces created throughout chew may be important. The position of implants is set by the position and angle of adjacent teeth, lab simulations or by using computed tomography with CAD/CAM simulations and surgical guides called stents. The stipulations to semipermanent success of osseointegrated dental implants area unit healthy bone and animal tissue. Since each will atrophy once tooth extraction pre-prosthetic procedures, like sinus lifts or animal tissue grafts, area unit typically needed to recreate ideal bone and animal tissue. GCC's report, Global Dental Implant Market Forecast and Analysis 2016-2021, has been ready based on the synthesis, analysis, and interpretation of information about the global Dental Implant market collected from specialized sources. The report covers key technological developments within the recent times and profiles leading players within the market and analyzes their key ways. The competitive landscape section of the report supply a transparent insight into the market share analysis of key trade players. The major players within the world implant market are Nobel Biocare, Straumann, framing Dental, BIOMET 3i, Dentsply, BioHorizons, Osstem. The report supply separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, world competitive landscape and supply/demand pattern of implant trade has been provided. Please enable US to grasp if you have associate special demand which we will give you with an updated report as per your demand. Get more details at https://franknraf.com/reports/global-dental-implant-market-forecast-and-analysis-2016-2021/ Request for to induce sample report Self Priming Pump business research Report at https://franknraf.com/sample-report/?rpt_id=6067 Company Name: Frank n Raf Market Research US: +1 347-321-6773 Related Reports: 2015-2023 World Platelet Agitators Market Research Report By Product Type, End-User / Application and Regions / Countries 2015-2023 World Implantable Neurostimulation Devices marketing research Report By Product sort, End-User / Application and Regions / Countries Europe Acute coronary failure (AHF) medical specialty trade state of affairs And Prospects analysis Report 2015-2023 World Medication Adherence Packaging Systems marketing research Report By Product sort, End-User / Application and Regions / Countries (Added: Sat Feb 02 2019 Hits: 33 Rating: 0.00 Votes: 0) Rate It

• Cancer Conference 2019 - 24th Annual meet on Surgical Oncology during March 04-05, 2019 at Paris, France. Surgical Oncology 2019 focuses on the theme let’s work together to live in a cancer free world. This Cancer Summit aims to bring together researchers on cancer and practitioners in Oncology from industry, Oncologists, surgeons, distinguished delegates, health research and development manufacturers in cancer research around the world and aims in accelerating scientific discovery towards the research in eradicating Cancer. (Added: Sat Feb 02 2019 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• Telehealth Market: Rise in Cardiovascular Diseases to Propel the Demand - Owing to the increase in geriatric population and rise in cardiovascular diseases, the global telehealth market is anticipated to witness a rapid growth rate. The competitive landscape of the market is highly fragmented regarding the number of players who provide services like hardware and software. Due to the increase in the number of chronic diseases like asthma, cancer and diabetes, there is the flow of demand for self-care solutions or devices. This is accompanied by the advancement in technology in terms of mobile health care and medical imaging which further boosts the telehealth market globally. Read Report Overview: https://www.transparencymarketresearch.com/telehealth-market.html There are a number of factors contributing to the growth of the telehealth market like the information and communication technology or ICT, advancement in mobile perforation, and connectivity. Since mobile access is pervasive all around the globe, it is easier for the telehealth market to prevail with time. There is rise in remote monitoring solution adoption by patients in rural areas may also add to the growth of the telehealth market globally. The telehealth market can also be expected to draw a large share of revenue owing to factors like effective image transfer, consistent evolution in communication and information technologies, and reporting and consultation. Adding to that, the scarce population of radiologists present around the world may also add to the increase in the overall growth of the telehealth market globally. The global telehealth market is anticipated to expand at a CAGR of 13.0% within the forecast period of 2017 to 2025. Previously the market was valued at US$ 6.0 bn as of the 2016 records. The rising number of chronic diseases and their concern is presumed to expand the growth of the global telehealth market during the forecast period. The global telehealth market is segmented on the basis of component, where the key classifications are services, software and hardware. The software segment is further classified into standalone software and integrated software. The services segment is further categorized into remote monitoring, store and forward, and real-time services. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41591 On the basis of application, the global telehealth market is classified as dermatology, psychiatry, remote intensive care unit or remote ICU, urgent care, cardiology and radiology. Cardiology, of all, seems to attract more revenue into the market and is anticipated to be the key application of telehealth. Increase in cardiovascular diseases and more heart diseases like strokes and attacks may account for almost about 19 percent share contribution to the telehealth market in the years to come. The end-user category is further segmented into patients, providers and payers. Among these, the payers segment is expected to expand with CAGR during 2017 to 2025. This is because of the rising adoption of connected medical and telehealth devices provided by insurance companies for claiming their insurance management. The global telehealth market is studied on the basis of key geographies Middle East and Africa, Latin America, Asia Pacific, Europe and North America. With regard to revenue, North America is seen to be having the dominance over the market all around the globe in the forecast period. This is due to the government initiatives taken in order to enlarge the adoption of telehealth services. So, North America is anticipated to continue its dominance over the telehealth market in the future years as well. The market is Asia Pacific is also presumed to expand at a notable CAGR rate during the forecast period. This due to the large number of patients who suffer from chronic diseases along with the aging population and also the heavy demand for improving the health infrastructure and cutting down health care expenditure, in developing nations of Australia, China, and India. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41591 Some of the key players in the global telehealth market are American Well, Honeywell International, Inc., Royal Philips, Aerotel Medical Systems Ltd., and Medtronic. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Sat Feb 02 2019 Hits: 124 Rating: 0.00 Votes: 0) Rate It

• Nurse Call Systems Market: Substantial Growth in Healthcare Expenses to Boost Growth - Growth of the nurse call systems market is gaining traction due to substantial growth in health care expenses, increasing the popularity of medical insurance mainly in the developing economies such as India and China, technological headways, and product upgradation. In addition, numerous government is imposing strict regulation on the usage of nurse call systems which are acting in the favor of growth of the nurse call systems market. These systems help in the consumer care and availability of the information for essential healthcare departments are some of the factors bolstering the growth of the global nurse call systems market. Read Report Overview: https://www.transparencymarketresearch.com/nurse-call-system-equipment-market.html However, the high cost of implementation and lack of trained professionals of both the healthcare and IT are limiting growth of the global nurse call systems market. According to the report by TMR, the global market for nurse call systems is anticipated to expand at a CAGR of around 10.9% from 2017 to 2025 to attain a value of US$2,665.98 mn by the end of forecast period. On the basis of equipment-type, the global nurse call systems market is segmented in to nurse call intercoms, basic audio/ visual nurse call systems, digital nurse call systems, IP-based nurse call systems, and nurse call mobile systems. Of these, IP-based nurse call systems dominated the global nurse call systems market in 2016 owing to the flexibility of installation such as installation in phases. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2173 On the basis of communication technology, the global nurse call systems market is segmented into wireless communication and wired communication. Of these, wired communication dominated in the market and expected to continue its dominance over the forecast period. This growth is attributable to the various government norms mandating for the wired infrastructure in acute care. On the basis of end-users, the market is segmented into hospitals, assisted living centers, nursing homes, and clinics. Of these, hospitals segment is dominating the global market and expected to continue its dominance over the forecast period. Thanks to higher adoption from hospitals than other segments. The patient-centric approach from the hospitals is fuelling growth of the global nurse call systems market. On the basis of region, the global nurse call systems market is segmented into North America, Europe, Asia Pacific, Latin America, and Rest of the World. Of these, in 2016, North America dominated the global nurse call systems market and expected to continue its dominance over the forecast period. This growth is attributable to the high elderly population in the region. However, Asia Pacific region is anticipated to grow with higher CAGR over the forecast period due to higher adoption of secure and wired nurse call solutions in nursing facilities for acute care. Additionally, improving healthcare infrastructure and improved access, flexibility, and mobility of the wireless communications are expected to fuel growth of the nurse call systems market presence in Asia Pacific. Key players operating in the nurse call systems market include Azure Healthcare Ltd., Cornell Communications, Hill-Rom Holdings, Inc., Ascom Holding AG, and TekTone Sound & Signal Mfg., Inc. The majority of the leading players are relying on the recent innovations in order to stand different from other competitors. These companies are increasingly taking part in the activities such as partnership, collaborations, and mergers for business expansion and improving product portfolio. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2173 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/  ^pop (Added: Sat Feb 02 2019 Hits: 118 Rating: 0.00 Votes: 0) Rate It

• Telemedicine Market: Expansion of the Computerized Well-Being Stages to Boost Growth - The rapid development of the healthcare industry and the expansion of the computerized well-being stages, which are projected to enhance the growth of the global tele-medicine market in the next few years. The advent of computerized health stages in order to enhance the remote checking of patients and the increment of healthcare conveyance efficiencies are further estimated to support the market growth in the coming few years. In addition to this, the rise in the awareness among people concerning the benefits of telemedicine is projected to propel the telemedicine market across the globe in the near future. The rising research activities and the increasing investments for innovations are likely to provide promising growth opportunities in the next few years. Read Report Overview: https://www.transparencymarketresearch.com/telemedicine-market.html As per the research report by Transparency Market Research, in 2014, the global market for telemedicine stood at US$14.3 bn and is estimated to attain a value US$36.3 bn by the end of 2020. The market is likely to register a promising 14.30% CAGR between 2014 and 2020. The global market for telemedicine has been classified on the basis of service type into tele-care, tele-surgery, tele-consultation, tele-monitoring, tele-training, and tele-education. Among these, the tele-consultation segment is predicted to hold a major share of the market in the next few years. The rise in the geriatric population and the increasing prevalence of cardiovascular and diabetes are the few factors that are estimated to enhance the market growth in the next few years. In addition to this, the rising cases of Parkinson’s and Alzheimer’s is another factor that is estimated to support the market growth in the near future. The rise in the demand for continuous monitoring of patients is predicted to boost the demand for tele-monitoring in the near future. Furthermore, the tele-training, tele-education, and tele-surgery segments are predicted to witness healthy growth in the coming few years. Among the major regional segments, a large share of the global telemedicine market is expected to be held by North America. As per the research study, this region is estimated to remain in the dominant position in the next few years, thanks to the presence of several leading players. Furthermore, Asia Pacific is estimated to witness a strong growth in the next few years holding a significant share of the global telemedicine market. The high growth of this region can be attributed to the rise in the urban and rural population and the increasing government initiatives. In addition to this, the rising focus on advancements and improvements in this field and the presence of several manufacturing units, who are providing comparatively cheaper equipment, thus encouraging the overall growth of the market in the near future. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3032 The global market for telemedicine is developing at a rapid rate with a participation of a large number of local as well as international players operating in it. The development of new products and the rising focus on the research and development activities are projected to support the growth of the global telemedicine market in the next few years. In addition to this, the market players are emphasizing on advertising and marketing and creating an awareness among people concerning the benefits of telemedicine, which is estimated to accelerate the growth of the market in the next few years. The key players operating in the telemedicine market across the globe are Siemens Healthcare, Allscripts Healthcare Solutions, Inc., Agfa HealthCare NV, AMD Global Telemedicine, Inc., CISCO Systems, Inc., CARDIOCOM, LLC, F. Hoffmann-La Roche Ltd., InTouch Technologies, Inc., Honeywell HomMed LLC, LifeWatch AG, Medtronic, Inc., and McKesson Corp. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Sat Feb 02 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• Endoscopic Clips Market: Rise in Demand for Endoscopic Treatment to Boost Growth - Endoscopic clips are specialized instruments. These clips are designed to achieve tissue approximation in gastrointestinal endoscopy. These were first introduced for the sole purpose of achieving hemostasis of gastrointestinal bleeding, especially peptic ulcer bleeding. Read Report Overview: https://www.transparencymarketresearch.com/endoscopic-clips-market.html Usage of endoscopic clips has been expanded to a number of applications such as closure of perforations, Dieulafoy’s lesion, varices, bleeding arteries less than 2 mm, and polyps less than 1.5 cm in diameter in the GI tract. However, there are few concerns regarding accuracy, safety, and retention of these devices. The global endoscopic clips market is driven by increase in incidence of bleeding during surgeries. Endoscopic clips are widely used in hemostasis-related problems such as bleeding arteries and ulcers. In developing regions, improved health care infrastructure, rise in demand for endoscopic treatment, supportive government initiatives, and high acceptance of minimal invasive surgeries are factors fueling the growth of the market. However, unfavorable reimbursement policies, and safety and side effects due to usage of endoscopic clips restrain the global market. The global endoscopic clips market has been segmented based on application, end-user, and region. In terms of application, the global market has been classified into endoscopic marking, hemostasis, and others. The hemostasis segment has been divided into mucosal/submucosal defects, bleeding ulcers, bleeding arteries, and polypectomy sites. Based on end-user, the global endoscopic clips market has been classified into hospitals, ambulatory surgical centers, clinics, and others. In terms of region, the global endoscopic clips market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=25967 The endoscopic marking segment is projected to expand at a high CAGR during the forecast period. The segment is anticipated to account for major share of the market by 2026. Hemostasis plays a vital role in stopping bleeding of ulcers and arteries. Endoscopic clips are also used for endoscopic marking, closure of perforations throughout the GI tract, post-operative anastomotic leakage, fluoroscopic-guided therapy, endoscopic repeat examination, and attachment of feeding tubes. Increase in the number of patients suffering from peptic ulcers, rise in use of endoscopy as an effective tool in diagnosis, prognostication, and therapy for bleeding ulcers drive the hemostasis segment. Additionally, endoscopic clips provide ease of use of delivery systems, reliable deployment, and better mucosal adherence, provide rotatability, better tissue retention, and appropriate opening distance of the arms. These factors fuel the growth of the global endoscopic clips market. Endoscopic clips are largely used as radiopaque markers. Precise marking before any surgical or minimally invasive surgical procedure helps to minimize the risk of recurrent bleeding. North America dominated the global endoscopic clips market in 2017, followed by Europe and Asia Pacific. Increase in demand for high-quality treatment, popularity of endoscopy devices, and technological advancements are the factors driving the market in these regions. Surge in health care expenditure, favorable reimbursement policies, rise in prevalence of GI tract diseases, and increase in the geriatric population are anticipated to propel the market in these regions during the forecast period. Asia Pacific is an emerging market for endoscopic clips. Increase in population, rise in disposable income, and expansion of key players in the region are the factors anticipated to boost the growth of the market in Asia Pacific. The market in Latin America and Middle East & Africa is expected to be driven by increase in cancer incidence, rise in patient population, improving economy, and investments made by governments. Key players operating in the global endoscopic clips market include Cook Endoscopy, Olympus America, Boston Scientific Corporation, CONMED Corporation, Medtronic, and Ovesco Endoscopy AG. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25967 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Feb 01 2019 Hits: 18 Rating: 0.00 Votes: 0) Rate It

• Preterm Birth and PROM Testing Market: Demand for Point-of-Care Testing Devices to Drive Growth - Premature rupture of membranes (PROM) is one of the leading causes of preterm births. Increase in number of preterm births due to rise in average age of women being pregnant and various health concerns such as diabetes and high blood pressure among women drive the global preterm birth and prom testing market. Additionally, increase in demand for point-of-care testing devices and rise in demand for cost effective diagnostic tests are the key factors propelling the market. However, lack of awareness about new technologies for diagnosis of preterm births and use of alternative diagnostic options such as ultrasound, transvaginal scan, uterine monitoring, and lab tests restrain the global market. Read Report Overview: https://www.transparencymarketresearch.com/preterm-birth-prom-testing-market.html Based on test type, the global preterm birth and PROM testing market has been bifurcated into preterm birth tests and PROM tests. The preterm birth tests segment has been classified into pelvic exam, ultrasound, uterine monitoring, and biomarkers. The PROM tests segment has been categorized into nitrazine test, ferning test, pooling, ultrasound, fetal fibronectin test, biomarkers, and others. Increase in the number of preterm births, high incidence of preterm births, rise in the number of specialty clinics, and easy detection of preterm birth through PROM tests are expected to augment the segment. In terms of revenue, the preterm birth tests segment dominated the global preterm birth and PROM testing market. However, availability of other tests in the market is likely to hamper the growth of the segment. In terms of end-user, the global preterm birth and PROM testing market has been divided into hospitals, diagnostic laboratories, and others. Increase in awareness about specialty treatments is a key driver of the diagnostic laboratories segment. Additionally, surge in demand for preterm diagnostic services and rise in the number of diagnostic procedures such as ultrasound and pelvic examinations for pregnant women are anticipated to propel the segment. The others segment is likely to witness strong growth during the forecast period due to shift of treatment toward nursing homes and specialized clinics. In terms of region, the global preterm birth and PROM testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Presence of key players, increase in demand for preterm birth testing, and rise in preterm birth rates are factors boosting the growth of the market in North America. Technological advancements, rise in the number of approvals for preterm and PROM tests from the European Commission, and increase in demand for preterm birth diagnostic tests propel the preterm birth and PROM testing market in Europe. Focus on early diagnosis of women’s health problems, rise in government initiatives toward maternal health, and increase in the number of preterm births are the major factors driving the market in Asia Pacific. Growth of the market in Latin America is attributed to rapid adoption of new technologies, increase in use of point-of-care testing devices & tools, and rise in the number of players offering products in the market. Additionally, surge in awareness about product offerings for preterm birth and PROM testing is expected to augment the market in Latin America during the forecast period. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=55416 Major players operating in the global preterm birth and PROM testing market include QIAGEN, Hologic, Inc., Medix Biochemica, Biosynex, Abbott Laboratories, Clinical Innovations, LLC, Sera Prognostics, Inc., The Cooper Companies, Inc., NX Prenatal, Inc., and IQ Products. Focus on technological advancements in preterm birth and PROM testing is expected to drive the global market during the forecast period. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Feb 01 2019 Hits: 18 Rating: 0.00 Votes: 0) Rate It

• Anesthesia Drugs Market Likely Boost the Industry Revenue and Demand till 2022 - The Global Anesthesia Drugs Market stood at USD 3.1 Bn in 2015 and is anticipated to catapult to USD 4.9 Bn by the end of 2022. As per the analysis of market Research Future (MRFR), the global anesthesia drugs market is likely to grow at a CAGR of 3.7% over the forecast period of 2015-2022. Anesthesia drugs are used during surgeries for loss of sensation to alleviate pain. The rise in global surgical volume across the globe has added to the growth of the global anesthesia market. There has been an increase in the number of surgical procedures to manage diverse health conditions such as cardiovascular diseases, malignancy, infections, injuries, etc. Such operative procedures require anesthesia drugs for pain management and induce high demand for anesthesia drugs. Moreover, post-operative pain management is also likely to contribute to the growth of the global anesthesia drugs market. Rise in global geriatric population is another factor contributing to the growth of the global anesthesia drugs market. The elderly populace is at more risk of acquiring cardiovascular, respiratory and other degenerative changes which often requires surgical treatments which boosts the growth of the market. To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/2508 Expanding healthcare sector in the emerging economies is expected to drive the market for anesthesia drugs. Growth in healthcare facilities would increase the number of surgeries in developing countries which would subsequently generate more demand for anesthetic drugs. A high incidence rate of emergency medical procedures is also a crucial factor in driving the market for anesthesia drugs. Besides, the rise in the number of cosmetic surgeries, and dental procedures also add fuel to the growth of the market Advancements in anesthesia drugs in terms of improved efficiency, additional and new mode of administration and decreased price has considerably augmented the growth of the market. However, the growth of the market might be hindered by side effects associated with anesthesia drugs such as temporary confusion, hallucination, elevation in heart rate and blood pressure, amnesia and memory loss, which is more prevalent in elderly patients. Other side effects include nausea, vomiting, sore throat, bladder problems, sleepiness, and others. Lack of skilled anesthesiologist is another crucial factor which might restrain the growth of the anesthesia drugs market. The regional segmentation of the global anesthesia drugs market segments the market into regional markets namely The Americas (North America & South America), Europe, Asia Pacific, and rest of the world (RoW). North America region is the largest market for anesthesia drugs, and it is a market bigger than South America due to advanced medical facilities being available there. The key players of this market are also based in North America, primarily in the United States of America (USA). After the USA, Canada is the biggest market in this region. Europe is the second largest market. Due to reasons same as the Americas, Western Europe market is bigger than the Eastern Europe market. In this region, the most important country based markets include France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Western Europe. During the forecast period, Asia Pacific region market is expected to grow at a significant rate. Medical facilities are becoming rapidly advanced in some countries like China, India, Japan, and South Korea. Hence, these countries are the crux of the Asia Pacific market, followed by the rest of the Asia Pacific region. Key Players for Global Anesthesia Drugs Market Market Research Future (MRFR) recognizes the following companies as the key players in Anesthesia Drugs Market: There are plenty of large and small market players which operate in this market all over the globe. The global anesthesia drugs market is led by some prominent players such as AstraZeneca PLC (British–Swedish), Baxter International Inc. (US), Fresenius Se & Co. Kgaa (Germany), Abbott Laboratories (US), Hospira, Inc. (US), Hikma Pharmaceuticals PLC (UK), F. Hoffmann-La Roche Ltd. (Switzerland), and AbbVie Inc. (US). Segmentation The global anesthesia drugs market has been segmented based on type of anesthesia, type of drugs and route of administration. By type of anesthesia, the market has been segmented into general anesthesia, regional anesthesia, and others. By type of drugs, the market has been segmented into general anesthetics, local anesthetics, and others. By route of administration, the market has been segmented into inhalation, intravenous, and others. To Browse Complete Report @ https://www.marketresearchfuture.com/reports/anesthesia-drugs-market-2508 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Fri Feb 01 2019 Hits: 16 Rating: 0.00 Votes: 0) Rate It

• Pick the Best Global Air Ambulance in Patna with LTV 1200 Ventilator - An Ambulance Service is used to avail the emergency shifting of the critical and needed patients to the required medical treatment center within a short span of time to avail the required treatment to the patients. Global Air Ambulance is well known for the quality services and at every stage. We provide world-class ICU setup such as PICU which is aimed to serve the need of the pediatric patient, NICU for neonatal or infant patient, IDM for Patient suffering from infectious diseases. Global Air Ambulance from Patna is mainly specialized in the shifting process of the critical and serious patients from one medicinal treatment center to another medical treatment center in another city to avail the required treatments as per the needs to cure their injuries. Patient Transfer By: Specialized Doctors Effective Medical Team With Advanced Medical Equipment Special Care Manageable Range If you need to transfer your patient from Patna and Varanasi then you are free to contact us anytime and from anywhere to book the most ergonomic Global Air Ambulance from Varanasi and Patna. The services shall be made available on affordable and competitive price. Web@ https://www.globalairambulance.in/air-ambulance-services-in-varanasi/ (Added: Fri Feb 01 2019 Hits: 17 Rating: 0.00 Votes: 0) Rate It

• Hybrid Operating Room Market Size, Share, Revenue Analysis and Forecasts to 2023 - A hybrid operating room is an alternative to conventional operating room equipped with advanced medical imaging systems and devices which support high quality interventional imaging and minimally invasive surgeries. It has complex environments in which numerous surgeons, nurses, anesthesiologists, and technicians work together. These are major factors that will drive growth of the market over the forecast period. Moreover, rising demand for advanced operating rooms and advanced equipment in healthcare domain across the world is expected to boost growth of the market. On the other hand, higher cost of hybrid operating room may hinder growth of the market during the forecasted period. The global hybrid operating room market is expected to grow at a healthy CAGR of 12.5% during the forecast period 2017-2023. Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/862 Key Players for Global Hybrid Operating Room Market Market Research Future (MRFR) recognizes the following companies as the key players in Hybrid Operating Room Market: There are plenty of large and small market players which operate in this market all over the globe. Some of the key players in the Global Hybrid Operating Room Market are Cook Medical Inc. (US), Eschmann Equipment (UK), General Electric Company (US), Johnson & Johnson Services, Inc. (US), Maquet Holding BV & Co. KG (Germany), Mediflex Surgical Products (US), Mizuho OSI (US), NDS Surgical Imaging (US), Koninklijke Philips N.V (the Netherlands), SISCO Ltd (India), STERIS plc.(US), and Siemens Healthcare GmbH (Germany) Segments for Global Hybrid Operating Room Market The global hybrid operating room is segmented by techniques, applications, and end users. On the basis of techniques, it is segmented into fluoroscopy & data acquisition, rotational angiography, digital subtraction angiography, and others. On the basis of applications, it is segmented into cardiovascular surgery, neurosurgery, thoracic surgery & endobronchial procedures, and others. On the basis of end users, it is segmented into hospitals, clinics, medical research firms, and others. Regional Analysis for Global Hybrid Operating Room Market The global hybrid operating room market consists of four regions namely the Americas, Europe, Asia Pacific, and the Middle East & Africa. The global hybrid operating room market is segmented into four regions including America, Europe, Asia Pacific and the Middle East & Africa. America dominates the global market due to governments backing more research and development activities in healthcare sector. Moreover, recent advances in the life sciences has boosted growth of this market. Europe holds the second position in the market as more number of people being encouraged for research and development and well-established & advanced healthcare sector. Asia Pacific is the fastest growing market due to the presence of huge opportunities and continuously increasing demand advanced hybrid operating room. Asia Pacific have undertaken various initiatives to educate people and surgeons about hybrid room. In particular, India is expected to be an emerging and the fastest growing market. On the other hand, the Middle East & Africa holds the lowest share in the global hybrid operating room market due to limited development in healthcare sector. Browse Complete Report @ https://www.marketresearchfuture.com/reports/hybrid-operating-room-market-862 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Fri Feb 01 2019 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• Smart Contact Lenses Market 2023 – Market Size, Share, Trends Analysis and Growth Forecast - Organ transplantation is the replacement of the diseased or damaged organ with a health organ. Organs such as a kidney may be donated by living donors or harvested from brain-dead organ donors. Organ dysfunction caused due to severe injuries, cancer, organ failure and/or genetic disorders necessitate the requirement for organ transplant procedures. Advances in technology and development in the medical sector has made transplantation possible. Kidney, heart, lungs, liver and many more can be transplanted. An increasing number of organ transplantation surgeries across the globe are the major driving factor for the growth of the market. Technological development, increasing prevalence of chronic diseases, rising aging population and changing lifestyle has also contributed to the growth of the market. However, high cost of treatment and increasing incident of organ failure has hampered the growth of the market. Global organ transplantation market is expected to grow at a CAGR of 9.8% during forecasted period 2017-2023. Browse Premium Sample Copy of 80 Premium Pages Report Enabled with Competitive Analysis of Niche Segments, Top Players, Comprehensive Research and Key Regions @ https://www.marketresearchfuture.com/sample_request/915 Key Players for Global Organ Transplantation Market The major key player for the Global Organ Transplantation Market are Novartis International AG (Switzerland), Terumo Medical Corporation (US), Transonic (US), F. Hoffmann-La Roche Ltd. (Switzerland), Astellas Pharma, Inc (Japan), Preservation Solutions, Inc. (US), OrganOX Limited (UK), Bio Med Pvt. Ltd. (US), Transplant Biomedical (UK), TransMedic, Inc. (US), Accord Healthcare GmbH (Spain), Sanofi (France), Pfizer, Inc. (US), Veloxis Pharmaceuticals A/S (Denmark), GlaxoSmithKline Plc. (UK) Global Organ Transplantation Market Competitive Analysis Global organ transplantation market is a competitive market. Major companies are investing in R&D so as to introduce more innovative and efficient methods and devices as they are under constant pressure to launch new and cost-effective method. Novartis International AG is a Swiss multinational company headquartered in Switzerland and is one of the largest pharmaceutical companies. They are the leading manufacturer of analgesic drugs. In 2016, company has acquired Selexys Pharmaceuticals to increase its market. Company has launched, Zortress is the first in over a decade approved by FDA to prevent organ rejection in adult liver transplant patients. Segments for Global Organ Transplantation Market Global organ transplantation market is segmented on the basis of type of organ, into heart, kidney, liver, lungs, and other. On the basis of products, they are segmented into organ preservation solutions, transplant diagnostics, tissue products and other. On the basis of type of transplant the market is segmented into autograft, allograft and allotransplantation, xenograft and xenotransplantation and other. On the basis of treatment the market is segmented into analgesic, immunosuppressant and other. Immunosuppressant is further segmented into calcineurin inhibitors, mTOR inhibitor, antiproliferative agents, steroids and other. Calcineurin Inhibitors are sub segmented into tacrolimus and cyclosporine. mTOR inhibitor is sub segmented into sirolimus and everolimus. On the basis of end users, the market is sub segmented into hospitals, transplant centers and other. Regional Analysis for Global Organ Transplantation Market Geographically, America dominate the global organ transplantation market. Increasing prevalence of organ failure, rapid development in the medical sector, well developed healthcare sectors and higher healthcare expenditure are the major factors for the growth of American market. Europe is the second largest organ transplantation, which is followed by Asia Pacific. Asia Pacific is the fastest growing region for this market. Presence of rapidly developing economies, and large population pole suffering from chronic diseases is the major driving factor for Asia Pacific market Browse Complete Report @ https://www.marketresearchfuture.com/reports/organ-transplantation-market-915 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Fri Feb 01 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... [>>]